RA Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,206,271
| Closed | -$35.5M | – | 84 |
|
|
2025
Q1 | $35.5M | Buy |
+3,206,271
| New | +$35.5M | 0.59% | 30 |
|
|
2024
Q3 | – | Sell |
-3,083,430
| Closed | -$51.7M | – | 86 |
|
|
2024
Q2 | $51.7M | Hold |
3,083,430
| – | – | 0.68% | 36 |
|
|
2024
Q1 | $46.3M | Hold |
3,083,430
| – | – | 0.59% | 42 |
|
|
2023
Q4 | $46.3M | Buy |
3,083,430
+1,599,733
| +108% | +$24M | 0.72% | 35 |
|
|
2023
Q3 | $20.8M | Buy |
+1,483,697
| New | +$20.8M | 0.41% | 48 |
|